Impact of infliximab therapeutic drug level monitoring on outcomes of patients with inflammatory bowel disease: A real-world experience from a Middle Eastern cohort

Nahla Azzam; Abdulrahman Aljebreen; Othman Alharbi; Aline Charabaty; Mohammed Alanazi; Nashmi Alkuwaykibi; Jowaher Alfaraidi; Ahmad Bashamil; Tarik Almansour; Majid Almadi

doi:10.1016/j.ajg.2021.01.001

Q2 2021

Impact of infliximab therapeutic drug level monitoring on outcomes of patients with inflammatory bowel disease: A real-world experience from a Middle Eastern cohort

Nahla Azzam · Abdulrahman Aljebreen · Othman Alharbi · Aline Charabaty · Mohammed Alanazi · Nashmi Alkuwaykibi · Jowaher Alfaraidi · Ahmad Bashamil · Tarik Almansour · Majid Almadi

10.1016/j.ajg.2021.01.001 388 Views 3 Citations

Citations

388

Views

Abstract not available for this publication.

Cite this Article (APA)

Nahla, A., Abdulrahman, A., Othman, A., Aline, C., Mohammed, A., Nashmi, A., Jowaher, A., Ahmad, B., Tarik, A., Majid, A. (2021). Impact of infliximab therapeutic drug level monitoring on outcomes of patients with inflammatory bowel disease: A real-world experience from a Middle Eastern cohort. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2021.01.001